B Bilgin Global Mod Global Mod 14 Nis 2022 #1 Glaxo to buy cancer-drug maker for $1.9 billion Buying Sierra Oncology is part of GlaxoSmithKline’s plans to bolster its pipeline of cancer treatments
Glaxo to buy cancer-drug maker for $1.9 billion Buying Sierra Oncology is part of GlaxoSmithKline’s plans to bolster its pipeline of cancer treatments